In the gastrointestinal (GI) tract, NF-1 is associated with neurofibroma, leiomyoma, and adenocarcinoma in the stomach, small and large bowel, vasculopathy, bleeding, pseudoobstruction, and protein-losing enteropathy.[1, 2]. Here, NF1 is linked to neurofibroma.